Page last updated: 2024-08-21

azomycin and Neglected Diseases

azomycin has been researched along with Neglected Diseases in 15 studies

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's11 (73.33)24.3611
2020's4 (26.67)2.80

Authors

AuthorsStudies
Bayão, TS; Cupertino, MDC; Gomes, AP; Siqueira-Batista, R1
Carneiro, CM; Carvalho, LM; Correa-Oliveira, R; de Carvalho, TV; Fonseca, KDS; Madeira, JV; Medeiros, LDF; Molina, I; Perin, L; Vieira, PMA1
Bangher, M; Bosch-Nicolau, P; Correa-Oliveira, R; de Paula, AMB; Eloi, S; Fernández, ML; Molina, I; Molina-Morant, D; Ribeiro, ALP; Salvador, F; Sanchez-Montalva, A; Sosa-Estani, S; Sulleiro, E; Villar, JC1
Cunha-Neto, E; Kalil, J; Moore, CE; Nascimento, MS; Pandey, RP; Raj, VS1
Bahia, MT; Diniz, LF; Gonçalves, KR; Mazzeti, AL; Mota, SLA; Pereira, DE1
Melton, L1
Forsyth, CJ; Garcia Bournissen, F; Kratz, JM; Sosa-Estani, S1
Burki, T1
Fujikura, Y; Imai, K; Iwata, O; Kawana, A; Kurane, I; Maeda, T; Mikita, K; Misawa, K; Miura, S; Miyahira, Y; Nagumo, M; Ono, T; Sayama, Y1
Briceno, L; Mosca, W1
Pays, JF1
Maxmen, A1
Clayton, J1
Barrett, MP; Brun, R; Don, R; Jacobs, RT; Wang, MZ1

Reviews

4 review(s) available for azomycin and Neglected Diseases

ArticleYear
New Approaches for the Treatment of Chagas Disease.
    Current drug targets, 2021, Volume: 22, Issue:7

    Topics: Animals; Chagas Disease; Drug Repositioning; Humans; Neglected Diseases; Nifurtimox; Nitroimidazoles; Trypanocidal Agents; Trypanosoma cruzi

2021
Clinical and pharmacological profile of benznidazole for treatment of Chagas disease.
    Expert review of clinical pharmacology, 2018, Volume: 11, Issue:10

    Topics: Animals; Chagas Disease; Drug Resistance; Humans; Neglected Diseases; Nitroimidazoles; Public Health; Trypanocidal Agents

2018
[What is not searched, it is difficult to find: Chagas' disease].
    Giornale italiano di cardiologia (2006), 2016, Volume: 17, Issue:5

    Topics: Chagas Cardiomyopathy; Chagas Disease; Emigrants and Immigrants; Humans; Italy; Neglected Diseases; Nifurtimox; Nitroimidazoles; Prevalence; South America; Treatment Outcome; Trypanocidal Agents; Trypanosoma cruzi

2016
Development of novel drugs for human African trypanosomiasis.
    Future microbiology, 2011, Volume: 6, Issue:6

    Topics: Animals; Antiprotozoal Agents; Benzoxazoles; Clinical Trials as Topic; Disease Models, Animal; Drug Evaluation, Preclinical; Haplorhini; Humans; Mice; Neglected Diseases; Nitroimidazoles; Trypanosoma brucei brucei; Trypanosomiasis, African

2011

Trials

1 trial(s) available for azomycin and Neglected Diseases

ArticleYear
Efficacy and safety assessment of different dosage of benznidazol for the treatment of Chagas disease in chronic phase in adults (MULTIBENZ study): study protocol for a multicenter randomized Phase II non-inferiority clinical trial.
    Trials, 2020, Apr-15, Volume: 21, Issue:1

    Topics: Adult; Aftercare; Argentina; Brazil; Case-Control Studies; Chagas Disease; Chronic Disease; Colombia; Double-Blind Method; Female; Humans; Male; Neglected Diseases; Nitroimidazoles; Parasite Load; Safety; Spain; Treatment Outcome; Trypanocidal Agents; Trypanosoma cruzi

2020

Other Studies

10 other study(ies) available for azomycin and Neglected Diseases

ArticleYear
Fexinidazole and Human African Trypanosomiasis: good news for this important neglected tropical disease.
    Revista da Sociedade Brasileira de Medicina Tropical, 2019, Volume: 52

    Topics: Humans; Neglected Diseases; Nitroimidazoles; Trypanocidal Agents; Trypanosomiasis, African

2019
Low-dose of benznidazole promotes therapeutic cure in experimental chronic Chagas' disease with absence of parasitism in blood, heart and colon.
    Experimental parasitology, 2020, Volume: 210

    Topics: Acute Disease; Animals; Blood; Chagas Disease; Chronic Disease; Colon; Cyclophosphamide; Female; Heart; Immunosuppression Therapy; Mice; Neglected Diseases; Nitroimidazoles; Real-Time Polymerase Chain Reaction; Trypanocidal Agents; Trypanosoma cruzi

2020
Combination therapy using nitro compounds improves the efficacy of experimental Chagas disease treatment.
    Parasitology, 2021, Volume: 148, Issue:11

    Topics: Animals; Chagas Disease; Drug Therapy, Combination; Female; Humans; Inhibitory Concentration 50; Mice; Neglected Diseases; Nifurtimox; Nitro Compounds; Nitroimidazoles; Real-Time Polymerase Chain Reaction; Sulfones

2021
Spanish group defeats Shkreli in Chagas voucher race.
    Nature biotechnology, 2017, 11-09, Volume: 35, Issue:11

    Topics: Chagas Disease; Drug Industry; Drug Utilization Review; Humans; Neglected Diseases; Nitroimidazoles; Spain; Trypanocidal Agents; United States; United States Food and Drug Administration

2017
Recognition for Chagas disease.
    The Lancet. Infectious diseases, 2019, Volume: 19, Issue:7

    Topics: Chagas Disease; Humans; Latin America; Neglected Diseases; Nitroimidazoles; Trypanocidal Agents; Trypanosoma cruzi

2019
Mother-to-child transmission of congenital Chagas disease, Japan.
    Emerging infectious diseases, 2014, Volume: 20, Issue:1

    Topics: Adolescent; Chagas Disease; Humans; Infectious Disease Transmission, Vertical; Japan; Male; Neglected Diseases; Nitroimidazoles; Treatment Outcome; Trypanocidal Agents; Trypanosoma cruzi

2014
[The third and new face of Chagas disease].
    Bulletin de la Societe de pathologie exotique (1990), 2016, Volume: 109, Issue:3

    Topics: Adult; Chagas Cardiomyopathy; Chagas Disease; Chronic Disease; Disease Progression; Humans; Neglected Diseases; Nitroimidazoles; Treatment Failure

2016
Vouching for access.
    Nature medicine, 2016, 07-07, Volume: 22, Issue:7

    Topics: Chagas Disease; Cholera; Cholera Vaccines; Drug Approval; Drug Costs; Health Policy; Health Services Accessibility; Humans; Neglected Diseases; Nitroimidazoles; Trypanocidal Agents; United States; United States Food and Drug Administration

2016
Busting the billion-dollar myth: how to slash the cost of drug development.
    Nature, 2016, 08-25, Volume: 536, Issue:7617

    Topics: Africa; Amodiaquine; Anti-Bacterial Agents; Artemisinins; Benzamides; Boron Compounds; Child; Clinical Trials as Topic; Cooperative Behavior; Developed Countries; Developing Countries; Drug Approval; Drug Combinations; Drug Costs; Drug Discovery; Drug Industry; Drug Repositioning; Drug Resistance, Microbial; Female; Humans; Malaria; Neglected Diseases; Negotiating; Nitroimidazoles; Organizations, Nonprofit; Sample Size; Trypanosomiasis, African; World Health Organization

2016
Chagas disease 101.
    Nature, 2010, Jun-24, Volume: 465, Issue:7301

    Topics: Acute Disease; Animals; Carrier State; Chagas Disease; Chronic Disease; Clinical Trials as Topic; History, 16th Century; History, 19th Century; History, 20th Century; History, 21st Century; History, Ancient; Humans; Insect Vectors; Latin America; Neglected Diseases; Nitroimidazoles; Trypanocidal Agents; Trypanosoma cruzi

2010